Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2021 08:00 ET | Source: Daré Bioscience, Inc.

Daré Bioscience to Host Second Quarter 2021 Financial Results and Company Update Conference Call and Webcast on August 12, 2021

SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30...
July 26, 2021 08:00 ET | Source: Daré Bioscience, Inc.

Daré Bioscience to Present at the 2021 Controlled Release Society Virtual Annual Meeting to be held July 25-29, 2021

Presentation will highlight the positive topline results from the DARE-BVFREE Phase 3 randomized, double-blinded, placebo-controlled clinical trial evaluating Daré’s product candidate DARE-BV1 in...
July 12, 2021 05:45 ET | Source: Daré Bioscience, Inc.

Daré Announces Collaborative Research Agreement (CRADA) for the Pivotal Phase 3 Study of Ovaprene®, an Investigational Hormone-Free Monthly Contraceptive

Funding and Clinical Operations Support will be Provided by the National Institutes of Health’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Under the CRADA ...
June 28, 2021 08:00 ET | Source: Daré Bioscience, Inc.

Daré Bioscience Announces Positive Phase 1 Results for DARE-HRT1

Results Support Potential as the First Monthly Therapy for both the Vasomotor and the Vaginal Symptoms of Menopause The First Clinical Study Using the Novel Segmented Intravaginal Ring (IVR)...
June 04, 2021 08:00 ET | Source: Daré Bioscience, Inc.

Daré Bioscience to Present at 2021 BIO Digital

SAN DIEGO, June 04, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it has been selected to deliver a company presentation...
May 13, 2021 08:00 ET | Source: Daré Bioscience, Inc.

Daré Bioscience Reports First Quarter 2021 Financial Results and Provides a Company Update

SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the quarter ended March 31, 2021 and...
May 06, 2021 08:00 ET | Source: Daré Bioscience, Inc.

Daré Bioscience to Host First Quarter 2021 Financial Results and Company Update Conference Call and Webcast on May 13, 2021

SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30...
April 27, 2021 08:00 ET | Source: Daré Bioscience, Inc.

Daré Bioscience Announces Ovaprene®, a Novel Investigational Hormone-Free Contraceptive, Poster Presentation at the 2021 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists

SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that data from the Company’s postcoital test (PCT) clinical...
April 26, 2021 08:00 ET | Source: Daré Bioscience, Inc.

Daré Bioscience Announces the Presentation of DARE-BVFREE Phase 3 Clinical Trial Results at the 2021 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists

SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that data from the DARE-BVFREE Phase 3 study of DARE-BV1, a...
April 19, 2021 08:00 ET | Source: Daré Bioscience, Inc.

Daré Bioscience Appoints Dr. Sophia N. Ononye-Onyia to its Board of Directors

SAN DIEGO, April 19, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced the appointment of Sophia N. Ononye-Onyia, PhD MPH MBA to...